Part 2 proceeding-use prohibition

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

Live 42 CFR 2.13(a) permits use or disclosure of Part 2 records only as the regulations allow and otherwise bars their use or disclosure in civil, criminal, administrative, or legislative proceedings conducted by federal, state, or local authorities. Current section 2.31(d) requires proceeding consent to remain separate from consent for any other purpose. eCFR displays Title 42 as current through August 20, 2026 and last amended August 13, 2026.

The proceeding category is broad

The current confidentiality rule lists four proceeding types and every level of government. Intake should capture court or agency, jurisdiction, case, parties, target, stage, deadline, requester, records sought, testimony, and proposed use.

A legal document still needs Part 2 analysis

Subpoenas, warrants, summonses, discovery requests, administrative demands, legislative inquiries, and testimony notices carry different force. Route each to qualified counsel and preserve any patient consent, authorizing court order, objection, motion, production, and disclosure record.

Hold and preserve while review proceeds

Apply legal holds, prevent routine deletion, restrict exports, preserve audit logs and source records, identify custodians, protect clinical operations, and track deadlines. A hold preserves information; it supplies no permission to disclose it.

Classify the proceeding and proposed use

Record tribunal or agency, jurisdiction, matter, case number, parties, patient target, stage, requester, legal instrument, records or testimony sought, purpose, deadline, custodians, and intended recipient. Include agency licensing, benefits, employment, legislative, and law-enforcement uses rather than limiting intake to conventional lawsuits.

Distinguish preservation, collection, review, disclosure, testimony, introduction into evidence, reliance in a decision, investigation, and downstream use. A step may be required operationally without supplying authority for the next step.

Verify the Part 2 route

Authenticate the request and route it to experienced counsel. If patient consent is proposed, verify the proceeding-specific elements, records, testimony, target, recipient, purpose, dates, signature, revocation, and separation under section 2.31(d). If an authorizing order is proposed, identify the applicable Part 2 subpart, findings, scope, protections, notice, and expiration.

A subpoena, warrant, discovery request, summons, agency demand, legislative inquiry, or testimony notice may have legal effect under another law while remaining insufficient by itself for Part 2. Preserve objections, motions, narrowing, protective terms, decision, and response.

Preserve without over-disclosing

Apply a legal hold to authoritative records, logs, messages, attachments, and relevant system data. Limit hold access, identify custodians, prevent routine deletion, and protect clinical operations. Keep preservation separate from production permissions.

For approved production, collect narrowly, review source and metadata, segregate unrelated patients and periods, redact or withhold as directed, verify the recipient, transmit securely, and maintain an index. Prepare testimony to the same scope. After the matter ends, remove temporary access and apply the supported disposition.

Example

Twelve proceeding requests are reviewed. Eight have record status, tribunal, target, proposed use, authority, scope, counsel decision, and response evidence; four show only a subpoena. Readiness is 8 of 12 requests.

Record the legal-response outcome

Classify each request as opposed, denied, narrowed, supported by proceeding-specific consent, supported by a matching Part 2 order, or unresolved. State patient target, matter, requester, records or testimony, purpose, dates, recipient, decision-maker, restrictions, and expiration. Preserve every version of the demand and response.

For unresolved requests, maintain the hold and restrict review access while counsel resolves authority. Track the deadline and safe acknowledgment without revealing patient status or producing information prematurely.

Before production or testimony, compare the final set and speaking scope with the decision. Afterward, verify receipt, preserve the index and transcript or notes, address corrections, and remove temporary access. A later supplemental demand or different use starts another review.

Audit a sample for overcollection, unsupported testimony, missed objections, and lingering working copies. Record corrective owner and verified closure.

Retain the audit date and reviewer.

Proceeding-use checklist

• identify matter, tribunal, target patient, requester, proposed use, scope, and deadline;
• separate preservation, collection, review, production, testimony, and later reliance;
• verify proceeding-specific consent or the exact Part 2 authorizing order;
• preserve objections, protective terms, withheld material, and counsel decisions;
• minimize, secure, and index any approved records or testimony; and
• remove temporary access and document final disposition after the matter.

This prohibition does not provide legal advice on a demand or excuse failure to preserve records. Current Part 2, court and agency rules, state law, the instrument, patient target, and intended use require experienced counsel.